Evergreen Wealth Solutions’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Evergreen Wealth Solutions’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6,621	Closed	-$492K	–	105
2022 Q2	$492K	Buy	6,621 +2,711	+69%	+$204K	0.6%	54
2022 Q1	$351K	Sell	3,910 -6,091	-61%	-$562K	0.34%	72
2021 Q4	$1.12M	Buy	+10,001	New	+$1.21M	1.02%	30

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Evergreen Wealth Solutions's XBI Position: Q3 2022 in Review

Evergreen Wealth Solutions sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 6,621 shares — an estimated $492K sold.

Evergreen Wealth Solutions first reported a position in XBI in Q4 2021 and held it in 3 quarters. The position peaked at $1.12M in Q4 2021. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Evergreen Wealth Solutions reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
Evergreen Wealth Solutions sold 6,621 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $492K.
Evergreen Wealth Solutions first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 3 quarters.
Evergreen Wealth Solutions's State Street SPDR S&P Biotech ETF position peaked at $1.12M in Q4 2021.
704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Evergreen Wealth Solutions's 13F filing for Q3 2022, filed 14 Nov 2022.